These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28928704)

  • 1. Prediction of Cognitive Decline from White Matter Hyperintensity and Single-Photon Emission Computed Tomography in Alzheimer's Disease.
    Tabei KI; Kida H; Hosoya T; Satoh M; Tomimoto H
    Front Neurol; 2017; 8():408. PubMed ID: 28928704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities: a possible link between sarcopenia and cognitive impairment in patients with mild to moderate Alzheimer's disease.
    Weng X; Liu S; Li M; Zhang Y; Zhu J; Liu C; Hu H
    Eur Geriatr Med; 2023 Oct; 14(5):1037-1047. PubMed ID: 37330930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging Characteristics of Frailty Status in Patients with Alzheimer's Disease.
    Hirose D; Shimizu S; Hirao K; Ogawa Y; Sato T; Kaneko Y; Takenoshita N; Namioka N; Fukasawa R; Umahara T; Sakurai H; Watanabe R; Hanyu H
    J Alzheimers Dis; 2019; 67(4):1201-1208. PubMed ID: 30689570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and neuropsychological profiles of Alzheimer's disease with white matter hyperintensity in North China.
    Chen Y; Wang Y; Zhang M; Zhou Y; Zhang H; Li P; Wu J
    Front Neurol; 2024; 15():1436030. PubMed ID: 39416665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Analysis of White Matter Hyperintensity: Comparison of Magnetic Resonance Imaging Image Analysis Software.
    Tabei KI; Saji N; Ogama N; Abe M; Omura S; Sakurai T; Tomimoto H
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106555. PubMed ID: 35691185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease.
    Smith CD; Johnson ES; Van Eldik LJ; Jicha GA; Schmitt FA; Nelson PT; Kryscio RJ; Murphy RR; Wellnitz CV
    Brain Behav; 2016 Mar; 6(3):e00438. PubMed ID: 26925303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment.
    Hirao K; Yamashita F; Sakurai S; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    Geriatr Gerontol Int; 2021 Aug; 21(8):644-650. PubMed ID: 34105230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.
    Waldemar G; Christiansen P; Larsson HB; Høgh P; Laursen H; Lassen NA; Paulson OB
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1458-65. PubMed ID: 7798973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional cerebral blood flow and periventricular hyperintensity in silent cerebral infarction--comparison with multi-infarct dementia].
    Koshi Y; Kitamura S; Nagazumi A; Tsuganesawa T; Terashi A
    Rinsho Shinkeigaku; 1996 Jun; 36(6):746-51. PubMed ID: 8937195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia.
    Altamura C; Scrascia F; Quattrocchi CC; Errante Y; Gangemi E; Curcio G; Ursini F; Silvestrini M; Maggio P; Beomonte Zobel B; Rossini PM; Pasqualetti P; Falsetti L; Vernieri F
    J Clin Neurol; 2016 Apr; 12(2):201-8. PubMed ID: 27074295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Okita M; Shimizu S; Kanetaka H; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2019 Oct; 19(10):1036-1040. PubMed ID: 31489777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
    Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
    Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes.
    Tohgi H; Yonezawa H; Takahashi S; Sato N; Kato E; Kudo M; Hatano K; Sasaki T
    Neuroradiology; 1998 Mar; 40(3):131-7. PubMed ID: 9561514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of white matter hyperintensity on cognitive function in PD patients: a meta-analysis.
    Zhao W; Cheng B; Zhu T; Cui Y; Shen Y; Fu X; Li M; Feng Y; Zhang S
    Front Neurol; 2023; 14():1203311. PubMed ID: 37621858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent cognitive and affective differences in Alzheimer's and Parkinson's diseases in relation to MRI findings.
    Tokuchi R; Hishikawa N; Sato K; Hatanaka N; Fukui Y; Takemoto M; Ohta Y; Yamashita T; Abe K
    J Neurol Sci; 2016 Jun; 365():3-8. PubMed ID: 27206864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study.
    Brown DR; Hunter R; Wyper DJ; Patterson J; Kelly RC; Montaldi D; McCullouch J
    J Psychiatr Res; 1996; 30(2):109-26. PubMed ID: 8816305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.